Evidence map›Paper›PMID 41463684›Full record

ReviewAntibiotics (Basel, Switzerland)2025

Tetracyclines in the Modern Era: Global Consumption, Antimicrobial Resistance, Environmental Occurrence, and Degradation Techniques.

Yuliya Semenova, Larissa Makalkina, Natalya Glushkova, Abduzhappar Gaipov

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. The Oxytetracycline ProducerInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Pharmacological assessment of drugs retained in the 1Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  5. Review
  6. Multiple Independent Origins of TnAntibiotics (Basel, Switzerland) · 2026
    Article
  7. Occurrence of Phenotypic Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuliya SemenovaDepartment of Surgery, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan.ORCID 0000-0003-1324-7806
Larissa MakalkinaDepartment of Clinical Pharmacology, Astana Medical University, Astana 010000, Kazakhstan.
Natalya GlushkovaDepartment of Epidemiology, Biostatistics and Evidence-Based Medicine, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Abduzhappar GaipovDepartment of Clinical Medicine, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan.ORCID 0000-0002-9844-8772

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakh-stan AP26197511
6 · The paper itself

Abstract

Tetracyclines are among the oldest classes of antibiotics, with broad activity against Gram-positive and Gram-negative bacteria, as well as

Indexed as

antimicrobial resistanceantimicrobial stewardshipdegradationenvironmentone healthtetracyclines

Identifiers

PMID41463684
PMCPMC12729376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.